Donna M Huryn

20PUBLICATIONS
33CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsPowder and particle technologyPredictive and prognostic markersPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 03, 2025
Antitumor Efficacy of 1,2,4-Triazole-Based VCP/p97 Allosteric Inhibitors.

Neal Green, Matthew G LaPorte, William Paquette

|Jul 19, 2023
Optimization of 1,2,4-Triazole-Based p97 Inhibitors for the Treatment of Cancer.

Matthew G LaPorte, Celeste Alverez, Alexander Chatterley

|Apr 18, 2022
Validation of HDAC8 Inhibitors as Drug Discovery Starting Points to Treat Acute Kidney Injury.

Keith Long, Zoe Vaughn, Michael David McDaniels

|Apr 26, 2021
Affinity Capture of p97 with Small-Molecule Ligand Bait Reveals a 3.6 Å Double-Hexamer Cryoelectron Microscopy Structure.

Md Rejaul Hoq, Frank S Vago, Kunpeng Li

|Aug 14, 2020
Identification of a Novel Oleic Acid Analog with Protective Effects in Multiple Cellular Models of Friedreich Ataxia.

M Grazia Cotticelli, Roberto Forestieri, Shujuan Xia

|Oct 10, 2019
PTPRT epigenetic silencing defines lung cancer with STAT3 activation and can direct STAT3 targeted therapies.

Malabika Sen, Audrey Kindsfather, Ludmila Danilova

Pageof 4

Frequent Collaborators

7 joint publications

Mary P Watson

7 joint publications

Rebecca T Ruck

7 joint publications

Lara Kallander

5 joint publications

Christa E Müller